Osteopontin: An emerging therapeutic target in uraemic vascular disease

Cardiovascular Research

Volumn 98, Issue 3, 2013, Pages 332-333

  Zhang, Xin ^a   Eirin, Alfonso ^a   Lerman, Amir ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

EDITORIAL; GLOMERULONEPHRITIS; HEART FUNCTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; UREMIA; VASCULAR DISEASE;

ANIMALS; AORTIC DISEASES; ATHEROSCLEROSIS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; UREMIA;

EID: 84877975879     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt098     Document Type: Editorial

References (16)

1. U.S. Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011.
2. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
3. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008;19:213-216.
4. Arnlov J, Evans JC, Benjamin EJ, Larson MG, Levy D, Sutherland P et al. Clinical and echo-cardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study. Heart 2006;92:1514-1515.
5. Baber U, de Lemos JA, Khera A, McGuire DK, Omland T, Toto RDet al. Non-traditional risk factors predict coronary calcificationin chronic kidney disease ina population-based cohort. Kidney Int 2008;73:615-621.
6. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CEet al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92: 2163-2168.
7. Hirota S, Imakita M, Kohri K, Ito A, Morii E, AdachiSet al. Expressionof osteopontin messenger RNA by macrophages in atherosclerotic plaques.A possible association with calcification. Am J Pathol 1993;143:1003-1008.
8. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expressionin vascular smooth muscle cells. Kidney Int 2002;62:1724-1731.
9. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 1997;17:188-193.
10. Matsui Y, Rittling SR, Okamoto H, Inobe M, Jia N, Shimizu Tet al. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003;23:1029-1034.
11. Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003;107: 679-681.
12. Pedersen TX, Madsen M, Junker N, Christoffersen C, Vikesa J, Bro S et al. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. Cardiovasc Res 2013.
13. Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006;26:570-575.
14. Speer MY, Chien YC, Quan M, Yang HY, Vali H, McKee MDet al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005;66:324-333.
15. Kupfahl C, Pink D, Friedrich K, Zurbrugg HR, Neuss M, Warnecke Cet al. Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res 2000; 46:463-475.
16. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT et al. Osteo-pontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005;106:1232-1239.